Algerian-made anti-diabetes pharmaceutical to be exported to Europe and Gulf countries

Because of the great controversy surrounding the wonder drug against diabetes devised by Mr. Toufik Zaibet and the reluctance of the medical profession to ascertain its effectiveness and the delays in publishing the results of the experts on this subject, it was decided to launch its marketing as a complementary food and not as medicine, given the high demand of patients both inside and outside the country.

Indeed, a drug for it to be marketed, it must go through all the necessary steps, namely clinical trials with different phases, the temporary authorization of use and authorization for its launching onto the market after the establishment of the relevant experts’ opinions and solid clinical studies.

This is why it is likely that this would be marketed as an anti-diabetic adjuvant in the first week after Eid with a production of 50,000 units produced in private laboratories of Algiers, Oran and Constantine at a price not exceeding 1000 DA.

This Algerian-made “miracle drug” extolled by numerous patients will also be marketed in Saudi Arabia, in other Gulf countries as well as in Europe, notably in France, Italy and Switzerland.